Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
Severe acute malnutrition is responsible for nearly half of all child deaths globally and affects 17 million children annually
Read More
Tag: teduglutide
SMC endorses five new therapies for NHS Scotland
Scottish cost regulators have approved funding for five new therapies on the NHS, offering new treatment options for a range of conditions.
Read More
NICE turns down Shire’s Revestive for bowel condition
The National Institute for Health and Care Excellence has published draft guidelines rejecting NHS funding for Shire’s Revestive as a treatment for short bowel syndrome (SBS).
Read More
EU allows paediatric use of Shire’s Restive
European regulators have approved the use of Shire’s Restive in children with short bowel syndrome (SBS), a rare and potentially life-threatening gastrointestinal condition.
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
